ATLAS fair value
ATLAS has no fair value for this stock today.
Shanghai Yizhong Pharmaceutical stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Shanghai Stock Exchange · China
Prices as of Oct 27, 2026 · CNY
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Shanghai Yizhong Pharmaceutical a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥31.21 and CN¥38.02; in 9 out of 10, between CN¥26.21 and CN¥45.29. Estimated annual volatility is 57%.
ATLAS does not publish a fair value for 688091.SHG right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 688091.SHG has traded between CN¥33.80 and CN¥66.20. Today it is 47.6% below that high and 3% above its low.
On the business: net margin is 21.4%; it trades at 103.2 times earnings.
Its beta is -0.44: it tends to move less than the market.
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the research and development of anti-tumor drugs and related products in China.
Want to see everything about Shanghai Yizhong Pharmaceutical?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the research and development of anti-tumor drugs and related products in China.
48%: close to a coin flip. In half of the simulated outcomes, 688091.SHG ends the month between CN¥31.21 and CN¥38.02.
Shanghai Yizhong Pharmaceutical's market capitalization is CN¥7.2B. Its price-to-earnings (P/E) ratio is 103.2: you pay CN¥103.2 for each CN¥1.00 of yearly earnings.
ATLAS estimates annual volatility at 57%. In a typical month, half of the outcomes end between CN¥31.21 and CN¥38.02.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy